EUVIMEDEUVIMED entdecken
Leserbrief

Risk of infections with bispecific antibodies in B‐cell non‐Hodgkin lymphomas and multiple myeloma—The current state

Amrit S Gonugunta, Virginia Mohlere, Muhammad Bilal Abid iD

British Journal of Haematology · 2024-09 · 205 (3) · 1197-1201

DOI: 10.1111/bjh.19633 ↗

Kurz gefasst

Leserbrief in der Zeitschrift British Journal of Haematology, online erschienen am 09.07.2024. Verfasst von Amrit S Gonugunta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Department of Hematology/Oncology, The University of Texas Health Science Center at Houston, Houston, Texas, USA.

ORCID-Profile: Muhammad Bilal Abid

Zitieren

APA

Gonugunta, A. S., Mohlere, V., & Abid, M. B. (2024). Risk of infections with bispecific antibodies in B‐cell non‐Hodgkin lymphomas and multiple myeloma—The current state. British Journal of Haematology, 205(3), 1197-1201. https://doi.org/10.1111/bjh.19633

Vancouver

Gonugunta AS, Mohlere V, Abid MB. Risk of infections with bispecific antibodies in B‐cell non‐Hodgkin lymphomas and multiple myeloma—The current state. British Journal of Haematology. 2024;205(3):1197-1201. doi:10.1111/bjh.19633

BibTeX
@article{Gonugunta2024,
  author = {Gonugunta, Amrit S and Mohlere, Virginia and Abid, Muhammad Bilal},
  title = {Risk of infections with bispecific antibodies in B‐cell non‐Hodgkin lymphomas and multiple myeloma—The current state},
  journal = {British Journal of Haematology},
  year = {2024},
  volume = {205},
  number = {3},
  pages = {1197--1201},
  doi = {10.1111/bjh.19633}
}
Kostenlos starten →